Summary: Aetna, a CVS Health company, modified CPB 0295 covering peripheral atherectomy and thrombectomy devices, effective May 2, 2026. Here's what changes for billing teams.
CPB 0295 is Aetna's clinical policy bulletin governing coverage of peripheral atherectomy and thrombectomy devices — procedures used to remove plaque or clots from peripheral arteries and veins. The May 2, 2026 effective date makes this active now. The policy does not list specific CPT or HCPCS codes in the available data, but peripheral atherectomy and thrombectomy billing involves a defined set of vascular procedure codes that your team should already be tracking under this bulletin.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Peripheral Atherectomy and Thrombectomy Devices — CPB 0295 |
| Policy Code | CPB 0295 |
| Change Type | Modified |
| Effective Date | 2026-05-02 |
| Impact Level | High |
| Specialties Affected | Vascular surgery, interventional radiology, interventional cardiology, cardiovascular surgery |
| Key Action | Pull the current CPB 0295 Aetna policy document and compare your existing charge capture and prior authorization workflows against the updated medical necessity criteria before billing any peripheral atherectomy or thrombectomy claims |
Aetna Peripheral Atherectomy and Thrombectomy Coverage Criteria and Medical Necessity Requirements 2026
The Aetna peripheral atherectomy and thrombectomy coverage policy under CPB 0295 Aetna system governs whether these procedures clear medical necessity criteria for reimbursement. This is a high-stakes policy for vascular and interventional practices — atherectomy claims are already under scrutiny across payers, and a modification to CPB 0295 signals that Aetna has tightened, expanded, or restructured its criteria.
No specific policy detail is available in the source data for this update. That's not unusual for mid-cycle modifications — Aetna sometimes releases policy changes before the full bulletin text is indexed. Pull the current version directly at app.payerpolicy.org/p/aetna/0295.ed above and review what changed line by line.
What we do know from the structure of CPB 0295 historically: Aetna's coverage policy for peripheral atherectomy has distinguished between different vascular territories (iliac, femoral-popliteal, infrapopliteal), device categories (rotational, directional, laser, orbital atherectomy), and clinical presentations (critical limb ischemia, claudication, acute vs. chronic total occlusions). Medical necessity criteria under this policy have typically required documentation of severity of stenosis, prior conservative treatment, and ankle-brachial index findings.
For thrombectomy, the policy separates mechanical thrombectomy from pharmacomechanical thrombectomy, and coverage has historically required acute presentation criteria. If the May 2, 2026 modification touched any of these distinctions — especially infrapopliteal atherectomy or orbital atherectomy coverage — your claim denial rate will move fast.
Prior authorization requirements under CPB 0295 have been consistent: most peripheral atherectomy procedures require prior auth for Aetna commercial plans. Confirm whether the updated policy changes those thresholds or adds new prior authorization triggers for specific device types.
Aetna Peripheral Atherectomy and Thrombectomy Exclusions and Non-Covered Indications
Historically, CPB 0295 has designated certain peripheral atherectomy applications as experimental or investigational. These have included atherectomy for in-stent restenosis in some contexts, some uses of laser atherectomy, and atherectomy in specific anatomical locations where the clinical evidence hasn't met Aetna's coverage threshold.
The real issue with experimental designations in this policy area is that device technology moves faster than coverage policy updates. Orbital atherectomy, for example, sat in an ambiguous coverage zone for years before Aetna formalized its position. If this modification adds or removes experimental designations for any device category, that changes your exposure immediately.
Thrombectomy exclusions under prior versions of CPB 0295 have included elective or non-acute presentations, thrombectomy as a stand-alone procedure where surgical thrombectomy was the standard of care, and percutaneous thrombectomy devices without sufficient peer-reviewed clinical evidence. Check whether the updated policy revises any of these boundaries.
Coverage Indications at a Glance
Because no specific policy detail is available in the source data, the table below reflects the historical structure of CPB 0295. Treat this as a framework — verify every row against the actual updated policy text before relying on it for billing decisions.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Peripheral arterial atherectomy — iliac/femoral-popliteal territory | Verify against updated policy | Not listed in available data | Historically covered with medical necessity criteria met |
| Infrapopliteal atherectomy for critical limb ischemia | Verify against updated policy | Not listed in available data | Has been a contested coverage area; check for changes |
| Orbital atherectomy — peripheral arteries | Verify against updated policy | Not listed in available data | Coverage status has varied; high-risk indication to audit |
| Laser atherectomy — peripheral arteries | Verify against updated policy | Not listed in available data | Historically experimental in some contexts under CPB 0295 |
| Mechanical thrombectomy — acute peripheral arterial occlusion | Verify against updated policy | Not listed in available data | Historically covered; acute presentation criteria required |
| Pharmacomechanical thrombectomy — deep vein thrombosis | Verify against updated policy | Not listed in available data | Has been subject to experimental/investigational designation |
| Atherectomy for in-stent restenosis | Verify against updated policy | Not listed in available data | Has been non-covered in some CPB 0295 versions |
Pull the updated CPB 0295 document and map these indications against what the modified policy actually says. If your practice performs high volumes of any of these procedures, this table is your audit checklist.
Aetna Peripheral Atherectomy and Thrombectomy Billing Guidelines and Action Items 2026
The available source data doesn't include the full text of the May 2, 2026 modification. That makes your first action more urgent, not less.
| # | Action Item |
|---|---|
| 1 | Pull the updated CPB 0295 document immediately. Go to the Aetna clinical policy bulletins page and download the current version. The effective date of May 2, 2026 is already live. If you haven't reviewed the changes, you're already billing under a policy you haven't read. |
| 2 | Run a line-by-line comparison against the prior version. Policy modifications to peripheral atherectomy and thrombectomy billing guidelines almost always involve changes to specific criteria language — not wholesale rewrites. The difference between "severe" and "moderate-to-severe" stenosis as a coverage threshold can be worth hundreds of thousands of dollars in denied claims annually for a high-volume vascular practice. |
| 3 | Audit your prior authorization workflows before submitting new claims. If CPB 0295 Aetna changes the prior auth requirements — adds new device types that now require auth, or removes auth requirements for others — your team needs to know before the claim goes out, not after the denial comes back. |
| 4 | Check your medical necessity documentation templates against the updated criteria. Peripheral atherectomy and thrombectomy claims live or die on the clinical documentation. If Aetna modified what they need to see — ABI values, imaging findings, prior treatment history — update your operative note templates and intake documentation to match. |
| 5 | Flag infrapopliteal atherectomy and pharmacomechanical thrombectomy claims for manual review. These have historically been the highest-risk categories under CPB 0295 for coverage policy disputes. Any modification that touches these indications changes your claim denial exposure directly. |
| 6 | Confirm reimbursement rates haven't shifted. Policy modifications sometimes coincide with fee schedule adjustments. Verify that the procedures you're billing still carry the expected reimbursement under your Aetna contracts after the May 2, 2026 effective date. |
| 7 | Talk to your compliance officer if your practice has high volume in any single device category. Orbital atherectomy and laser atherectomy in particular have had volatile coverage histories across payers. If those represent meaningful revenue for your practice, loop in your compliance officer before the next round of claims goes out. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Peripheral Atherectomy and Thrombectomy Under CPB 0295
The available policy data does not list specific CPT, HCPCS, or ICD-10 codes. Do not assume your current charge capture is accurate without verifying against the updated policy text.
A Note on Peripheral Atherectomy and Thrombectomy Billing Codes
Peripheral atherectomy and thrombectomy billing involves a specific set of CPT codes tied to approach (open vs. endovascular), vascular territory, and device type. The absence of a code list in the available data doesn't mean CPB 0295 is code-agnostic — it means the code tables from the updated document weren't captured in this data pull.
Pull the actual policy document to get the authoritative code list. Peripheral atherectomy and thrombectomy procedures bill under distinct CPT codes depending on whether the approach is transluminal, the territory is above or below the knee, and whether the procedure is combined with angioplasty or stenting. Getting the wrong code pairing is a fast path to a claim denial.
Once you have the updated code list from CPB 0295, cross-reference it against your charge master and EHR order sets. Any code that appeared in a prior version of the policy but doesn't appear in the current version warrants a specific review.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.